Respiratory manifestations of panic disorder: causes, consequences and therapeutic implications.
Multiple respiratory abnormalities can be found in anxiety disorders, especially in panic disorder (PD). Individuals with PD experience unexpected panic attacks, characterized by anxiety and fear, resulting in a number of autonomic and respiratory symptoms. Respiratory stimulation is a common event during panic attacks. The respiratory abnormality most often reported in PD patients is increased CO2 sensitivity, which has given rise to the hypothesis of fundamental abnormalities in the physiological mechanisms that control breathing in PD. There is evidence that PD patients with dominant respiratory symptoms are more sensitive to respiratory tests than are those who do not manifest such symptoms, and that the former group constitutes a distinct subtype. Patients with PD tend to hyperventilate and to panic in response to respiratory stimulants such as CO2, triggering the activation of a hypersensitive fear network. Although respiratory physiology seems to remain normal in these subjects, recent evidence supports the idea that they present subclinical abnormalities in respiration and in other functions related to body homeostasis. The fear network, composed of the hippocampus, the medial prefrontal cortex, the amygdala and its brain stem projections, might be oversensitive in PD patients. This theory might explain why medication and cognitive-behavioral therapy are both clearly effective. Our aim was to review the relationship between respiration and PD, addressing the respiratory subtype of PD and the hyperventilation syndrome, with a focus on respiratory challenge tests, as well as on the current mechanistic concepts and the pharmacological implications of this relationship.
Sardinha
Aline
A
Laboratory of Panic and Respiration, Instituto de Psiquiatria, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. alinesardinhapsi@gmail.com
Freire
Rafael Christophe da Rocha
RC
Zin
Walter Araújo
WA
Nardi
Antonio Egidio
AE
D002245:Carbon Dioxide / Q000502:physiology; D004198:Disease Susceptibility; D006801:Humans; D006985:Hyperventilation / Q000188:drug therapy / Q000209:etiology / Q000523:psychology; D016584:Panic Disorder / Q000150:complications* / Q000188:drug therapy; D012120:Respiration Disorders / Q000188:drug therapy / Q000209:etiology* / Q000523:psychology
D002245:Carbon Dioxide